このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Mental Fatigue, Attentional Focus, and Countermovement Jump Performance

2026年8月19日 更新者:Oğuzhan Bozkurt、Inonu University

The Effects of Acute Mental Fatigue and Attentional Focus Instructions on Countermovement Jump Performance

This study examines whether short-term mental fatigue and different jump instructions affect how high people can jump. Thirty-two physically active university students will complete two testing sessions in random order: one after a 30-minute mentally tiring computer task and one after a 30-minute relaxing video. In both sessions, participants will perform vertical jumps while receiving one of three types of instructions: no special instruction, focusing on their own body movements, or focusing on pushing the ground away. The study will compare jump height across these conditions to better understand how mental tiredness and coaching cues affect jumping performance, which may help coaches and athletes design better training and competition preparation.

調査の概要

詳細な説明

This study uses a sex-stratified, randomized, counterbalanced crossover design with repeated measures to examine the effects of acute mental fatigue and attentional-focus instructions on countermovement jump (CMJ) performance. Thirty-two physically active undergraduate students (16 women, 16 men), aged 18-30 years, will be enrolled from the Faculty of Sport Sciences at İnönü University, Malatya, Türkiye.

Each participant will complete two experimental protocols, separated by at least 72 hours: a control protocol (approximately 30 minutes of passive viewing of a narration-free nature video) and a mental-fatigue protocol (a 30-minute computerized color-word Stroop interference task). Protocol order will be randomized and stratified by sex. In both protocols, participants will perform CMJs under three attentional-focus conditions, presented in a randomized order that is held constant within each participant across sessions: no prescribed focus, internal focus (attention directed to the participant's own body movements), and external focus (attention directed to the effect of movement on the environment). CMJ height will be recorded in centimeters using a validated video-based jump-analysis application (My Jump Lab) on a tablet camera recording at 240 frames per second, with the higher of two valid trials retained as the primary outcome for each protocol-by-focus condition.

Subjective mental fatigue will be assessed immediately before and after each protocol using a 0-10 visual analogue scale to confirm the effectiveness of the fatigue manipulation. Stroop task performance (total trials, accuracy) and adherence to the assigned attentional-focus instructions will be recorded as secondary measures.

The primary analysis will use a 2 (protocol: control, mental fatigue) x 3 (focus: no prescribed, internal, external) x 2 (sex: women, men) mixed-model ANOVA on CMJ height, with protocol and focus as within-participant factors and sex as a between-participant factor. Reporting will follow CONSORT 2025 and the CONSORT extension for randomized crossover trials.

研究の種類

介入

入学 (推定)

32

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Malatya、トルコ(Türkiye)、44280
        • İnönü University, Faculty of Sport Sciences
        • コンタクト:
        • 主任研究者:
          • Oguzhan BOZKURT, PhD

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • Age 18-30 years
  • Third- or fourth-year undergraduate student in the Faculty of Sport Sciences, İnönü University
  • Engaged in structured physical activity on at least 2 days per week
  • Normal or corrected-to-normal vision and normal color vision
  • Able to safely perform maximal vertical jumps

Exclusion Criteria:

  • Major lower-extremity surgery or injury
  • Musculoskeletal injury during the preceding 6 months that could affect jumping
  • Diagnosed neurological, psychiatric, or cardiovascular disorder
  • Regular use of medication that could influence alertness, fatigue, cardiovascular responses, or neuromuscular performance
  • Any health condition compromising safety or measurement validity

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Control-First Sequence
Participants complete the control protocol (30-min passive nature-video viewing) in the first session and the mental-fatigue protocol (30-min Stroop task) in the second session, separated by at least 72 hours. In both sessions, participants perform countermovement jumps under three attentional-focus conditions (no prescribed focus, internal focus, external focus) in a randomized, participant-fixed order.
Approximately 30 minutes of passive viewing of a narration-free nature video under standardized lighting, seating, and sound conditions, serving as the non-fatiguing control condition matched in duration to the mental-fatigue protocol.
A verbal cue delivered before each jump attempt with no directional attentional instruction: "When you are ready, jump as high as possible."
A verbal cue delivered before each jump attempt directing attention to the participant's own body movements: "When you are ready, focus on extending your knees and hips as quickly and explosively as possible while jumping as high as possible."
A verbal cue delivered before each jump attempt directing attention to the effect of movement on the environment: "When you are ready, focus on pushing the ground away from you as quickly and explosively as possible while jumping as high as possible."
実験的:Mental-Fatigue-First Sequence
Participants complete the mental-fatigue protocol (30-min Stroop task) in the first session and the control protocol (30-min passive nature-video viewing) in the second session, separated by at least 72 hours. In both sessions, participants perform countermovement jumps under three attentional-focus conditions (no prescribed focus, internal focus, external focus) in a randomized, participant-fixed order.
A verbal cue delivered before each jump attempt with no directional attentional instruction: "When you are ready, jump as high as possible."
A verbal cue delivered before each jump attempt directing attention to the participant's own body movements: "When you are ready, focus on extending your knees and hips as quickly and explosively as possible while jumping as high as possible."
A verbal cue delivered before each jump attempt directing attention to the effect of movement on the environment: "When you are ready, focus on pushing the ground away from you as quickly and explosively as possible while jumping as high as possible."
A 30-minute computerized color-word Stroop interference task delivered as one uninterrupted block on a custom program, in which participants identify the font color of color-word stimuli while ignoring word meaning, inducing acute mental fatigue prior to countermovement jump testing.
他の名前:
  • Color-Word Stroop Task

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Countermovement Jump Height
時間枠:Assessed once per attentional-focus condition (higher of two valid trials) approximately 30 seconds after completion of each 30-minute protocol (control or mental fatigue), across two sessions separated by at least 72 hours.
Vertical jump height, measured in centimeters, recorded using a validated video-based jump-analysis application (My Jump Lab) at 240 frames per second. The higher of two valid trials in each protocol-by-attentional-focus condition (control vs. mental fatigue x no prescribed focus, internal focus, external focus) will be retained as the outcome value for that condition.
Assessed once per attentional-focus condition (higher of two valid trials) approximately 30 seconds after completion of each 30-minute protocol (control or mental fatigue), across two sessions separated by at least 72 hours.

二次結果の測定

結果測定
メジャーの説明
時間枠
Subjective Mental Fatigue Rating
時間枠:Immediately before and immediately after each 30-minute protocol (control and mental fatigue), across two experimental sessions separated by at least 72 hours.
Self-reported mental fatigue rated on a 0-10 visual analogue scale, in response to "How mentally fatigued do you feel right now?" (0 = not mentally fatigued at all, 10 = the highest possible level of mental fatigue).
Immediately before and immediately after each 30-minute protocol (control and mental fatigue), across two experimental sessions separated by at least 72 hours.
Stroop Task Performance
時間枠:Continuously recorded throughout the 30-minute mental-fatigue protocol, administered in one of the two experimental sessions per participant (protocol order randomized).
Total trials completed, number of correct and incorrect responses, and accuracy (%), recorded automatically by the Stroop task software during the mental-fatigue protocol.
Continuously recorded throughout the 30-minute mental-fatigue protocol, administered in one of the two experimental sessions per participant (protocol order randomized).
Focus-Instruction Adherence
時間枠:Assessed once per attentional-focus condition, immediately after completion of each 30-minute protocol (control or mental fatigue), across two experimental sessions separated by at least 72 hours.
Self-reported adherence to the assigned attentional-focus instructions, rated on a 0-10 visual analogue scale.
Assessed once per attentional-focus condition, immediately after completion of each 30-minute protocol (control or mental fatigue), across two experimental sessions separated by at least 72 hours.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月1日

一次修了 (推定)

2026年10月1日

研究の完了 (推定)

2026年11月1日

試験登録日

最初に提出

2026年8月17日

QC基準を満たした最初の提出物

2026年8月19日

最初の投稿 (実際)

2026年8月21日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月21日

QC基準を満たした最後の更新が送信されました

2026年8月19日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する